Ceftaroline Fosamil Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds.Ceftaroline fosamil is a novel broad-spectrum cephalosporin approved by the EMA in 2012 for the treatment of adults with complicated skin and soft-tissue infections (cSSTIs) and community-acquired pneumonia (CAP) [18].Ceftaroline Fosamil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Ceftaroline Fosamil Nitroso Impurity 1 CAS NO:NA chemically represented as (Z)-2-(2-(5-Amino-1,2,4-thiadiazol-3-yl)-2-(ethoxyimino)acetamido)-2-(5-((4-(1-methylpyridin-1-ium-4-yl)thiazol-2-yl)thio)-3-nitroso-3,6-dihydro-2H-1,3-thiazin-2-yl)acetate . Synchemia is the leading manufacturing and exporter of Ceftaroline Fosamil Nitroso Impurity 1 . We supply Ceftaroline Fosamil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143252 |
| CAS No | NA |
| Mol.F. | C17H21ClN4O5 |
| Mol.Wt. | 396.83 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143253 |
| CAS No | NA |
| Mol.F. | C14H17ClN4O3 |
| Mol.Wt. | 324.77 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143254 |
| CAS No | NA |
| Mol.F. | C20H27ClN4O5 |
| Mol.Wt. | 438.91 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143255 |
| CAS No | NA |
| Mol.F. | C18H25BrN4O4 |
| Mol.Wt. | 441.33 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143256 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143257 |
| CAS No | NA |
| Mol.F. | C26H29Cl2N5O6 |
| Mol.Wt. | 578.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143258 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O7 |
| Mol.Wt. | 444.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143259 |
| CAS No | NA |
| Mol.F. | C18H25ClN4O5 |
| Mol.Wt. | 412.87 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143260 |
| CAS No | NA |
| Mol.F. | C18H23ClN4O4 |
| Mol.Wt. | 394.86 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143261 |
| CAS No | NA |
| Mol.F. | C10H9ClN2O5 |
| Mol.Wt. | 272.64 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143262 |
| CAS No | NA |
| Mol.F. | C10H8BrClN2O5 |
| Mol.Wt. | 351.54 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143263 |
| CAS No | NA |
| Mol.F. | C26H37N3O6 |
| Mol.Wt. | 487.60g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143264 |
| CAS No | NA |
| Mol.F. | C12H17N3O3 |
| Mol.Wt. | 251.29 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143265 |
| CAS No | NA |
| Mol.F. | C18H29N3O6 |
| Mol.Wt. | 383.45g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143266 |
| CAS No | NA |
| Mol.F. | C19H33N3O6 |
| Mol.Wt. | 399.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143267 |
| CAS No | NA |
| Mol.F. | C19H31N3O6 |
| Mol.Wt. | 397.47 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |